Last reviewed: June 25, 2026
Last updated: June 25, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Ozempic brand pens are manufactured in four preset strengths: 0.25 mg, 0.5 mg, 1 mg, and 2.4 mg per injection. However, the prescribed dose depends entirely on your clinical response and tolerance, not the pen size available. Many patients seeking personalized weight loss therapy find that commercial pens limit their dosing flexibility, which is why compounded semaglutide from licensed 503A pharmacies has become a practical alternative.
Ozempic Pen Strengths and Maximum Dosing
The highest-strength Ozempic pen delivers 2.4 mg of semaglutide per weekly injection, which is the maximum approved dose for weight management in the GLP-1 class. This pen is identical in physical size to lower-strength versions—the concentration simply changes. Patients typically start at 0.25 mg and increase by 0.25 mg increments every four weeks, reaching the 2.4 mg target over roughly 16 weeks of gradual titration.
Prescribers sometimes need to adjust doses between these standard steps—for example, 0.3 mg, 0.6 mg, 1.2 mg, or 1.8 mg—to match individual metabolism and tolerance. Standard Ozempic pens cannot accommodate these intermediate doses without wasting medication or requesting separate prescriptions. This rigid structure led to the expansion of compounded GLP-1 options that allow true dose customization.
How Compounded Semaglutide Differs from Brand Ozempic
Compounded semaglutide from licensed 503A compounding pharmacies contains the same active ingredient as Ozempic but is prepared in a pharmacy setting to meet individual patient needs. Unlike branded pens, compounded formulations allow prescribers to specify any dose within a safe range—not just the four fixed strengths. The medication is vials or syringes, giving both doctor and patient greater control over dose escalation and personalization.
PlexusDx partners with licensed 503A compounding pharmacies nationwide to deliver semaglutide injections at a flat $149 per month across all dose levels. This pricing model ensures your dose can increase as needed without your monthly cost rising. Patients maintain the same injection frequency (once weekly) and achieve the same clinical outcomes as brand therapy, with the added benefit of true dose flexibility and significant cost savings.
Dosing Flexibility and Titration Schedules
A typical semaglutide titration schedule increases the dose every 4 weeks over 16–20 weeks of treatment. Starting at 0.25 mg allows the body to adjust to GLP-1 signaling and reduces nausea and gastrointestinal side effects. Some patients respond excellently to 1 mg or 1.5 mg and do not need to continue all the way to 2.4 mg, while others benefit from reaching maximum dose or even staying slightly longer at intermediate steps.
Compounded semaglutide allows prescribers to slow or accelerate this timeline based on patient feedback and weight loss progress. If a patient develops significant side effects at a planned dose, the prescriber can maintain the current dose longer or increase more gradually. Conversely, patients with excellent tolerance can move through the titration schedule faster, reaching their target dose in 12 weeks instead of 20.
PlexusDx Semaglutide Pricing and Genetic Personalization
PlexusDx offers compounded semaglutide injections starting at $149 per month, with a simple pricing structure: your dose may need to go up, but your price won't. This flat-rate model removes the financial barrier that often discourages gradual, safe titration. All formulations are shipped nationwide to all 50 states with no insurance requirement, no membership fee, and HSA/FSA eligibility.
To optimize your semaglutide response even further, PlexusDx offers the Precision Peptide Genetic Test ($99 add-on after your first month) that analyzes key genetic variants affecting GLP-1 and GIPR signaling pathways. The test examines genes including GLP1R rs6923761 and GIPR rs1800437, which influence how your body responds to semaglutide dosing and titration speed. This genetic insight helps your prescriber personalize not just your dose, but your entire treatment timeline and expectations.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the largest Ozempic pen size available?
The largest Ozempic brand pen delivers 2.4 mg per injection and is the maximum approved dose for chronic weight management. However, many patients benefit from intermediate doses between the four preset strengths (0.25, 0.5, 1, and 2.4 mg). PlexusDx compounded semaglutide allows any custom dose within a safe range, giving your prescriber complete flexibility to match your individual needs.
Does increasing my semaglutide dose cost more with PlexusDx?
No. PlexusDx compounded semaglutide injections carry a flat monthly price starting at $149—whether you take 0.5 mg or 2.4 mg per week. Your dose may increase as your treatment progresses, but your price stays the same across all tiers.
How long does it take to reach the maximum semaglutide dose?
Standard titration takes 16–20 weeks, starting at 0.25 mg and increasing by 0.25 mg every 4 weeks. With compounded semaglutide from PlexusDx, your prescriber can adjust this timeline based on your tolerance, side effects, and weight loss response. Some patients safely reach target dose in 12 weeks; others benefit from a slower approach.
Are compounded semaglutide pens as effective as Ozempic?
Yes. Compounded semaglutide from licensed 503A pharmacies contains the same active pharmaceutical ingredient as Ozempic and achieves identical clinical outcomes in clinical practice. The main differences are dose flexibility, cost, and accessibility—not efficacy. PlexusDx sources all compounds from licensed 503A pharmacies, never 503B facilities.
How does the Precision Peptide Genetic Test help my dosing?
PlexusDx's Precision Peptide Genetic Test analyzes 14 metabolic pathways and 49 peptides, including GLP1R and GIPR variants that influence how quickly your body responds to semaglutide and how high your effective dose may need to be. This genetic insight allows your prescriber to predict your optimal titration speed and expected response, making your treatment more personalized from the start.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Can You Lose Weight with Wegovy Without Dieting?
What If I Forgot to Take My Wegovy Shot? Navigating Missed Doses and Sustaining Your Weight Loss Journey